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The semaphorin family comprises soluble and membrane-
bound proteins originally identiﬁed as axonal guidance cues that
function during neuronal development. Emerging evidence sug-
gests that a subset of semaphorins (sema3A, sema4A, sema4D,
sema6D, sema7A), called 'immune semaphorins', function in the
immune system. Sema3A use neuropilin-1/Plexin-A1 receptor
complex. Sema3A was required for DC transmigration and that
sema3A produced by the lymphatics promoted actomyosin
contraction at the trailing edge of migrating DCs.1 Sema4A and
Sema4D use Tim-2 and CD72, respectively, as receptors during im-
mune responses. On the other hand, sema4A and sema4D use
Plexin-B1 during cell migration and angiogenesis. Sema4A is pref-
erentially expressed on B cells and dendritic cells, and is involved
in the activation of T cells, whereas sema4D, which is expressed
constitutively by T cells, is involved in the activation of B cells
and dendritic cells.2 Sema4A enhances the in vitro activation and
differentiation of T cells and the in vivo generation of antigen-
speciﬁc T cells. In addition, the Sema4A receptor is Tim-2, a mem-
ber of the family of T-cell immunoglobulin domain and mucin
domain (Tim) proteins that is expressed on activated T cells.3 More-
over sema4A plays not only in T cell priming, but also in the regu-
lation of Th1/Th2 responses.4 And immune-cell-expressed ligand
sema4A and the Treg-cell-expressed receptor neuropilin-1 (Nrp1)
interact both in vitro, to potentiate Treg-cell function and survival,
and in vivo, at inﬂammatory sites.5 Sema4D plays a critical role in
immune responses by the novel mechanism of turning off negative
signaling by CD72. The sema4DeCD72 interaction results in strong
B cell costimulation by the mechanism of turning off negative
signaling.6 Sema7A use b1 integrin as receptor. Sema7A is highly
expressed on activated T lymphocytes and its localization in the
immunological synapse ampliﬁes pro-inﬂammatory cytokine
expression by antigen presenting cells.7 These immune semaphor-
ins and their receptors have been reported to be expressed in
various immune cells. However, there are not enough reports on
these effect on eosinophils. So we have examined the effect of im-
mune semaphorins on eosinophils.
Eosinophils were puriﬁed from heparinized peripheral blood of
healthy volunteers as previously described.8 It has already been re-
ported that sema7A receptor, b1 integrin is expressed on eosino-
phils. We examined gene expression of the other immune
semaphorin receptors (Neuropilin-1, Plexin-A1, Plexin-B1, CD-72)
in untreated and cytokine-treated eosinophils by RT-PCR. All recep-
tors' gene were expressed in untreated eosinophils and notPeer review under responsibility of Japanese Society of Allergology.
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NGFor VEGF (data not shown).We then investigated protein expres-
sion of the receptors by ﬂow cytometry. These receptors were not
expressed on the surface of untreated and cytokine-treated eosino-
phils (data not shown). Next, we tested the effect of sema4A and
sema4D on O2 generation induced by IL-5 (10 ng/ml) or GM-CSF
(1 ng/ml). Superoxide generation was measured by a cytochrome
C reduction method as described elsewhere.9 Sema4A and sema4D
(1 ng/ml) did not have any effect on the enhanced O2 generation
(data not shown). Finally, we tested the effect of semaphorin 3A,
4A, 4D and 7A on cytokine and chemokine production induced by
IL-5 (10 ng/ml) or GM-CSF (1 ng/ml). A panel of cytokines and che-
mokines (IL-1a, IL-1b, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-
12p40, IL-12p70, IL-13, IL-15, IL-17, TNFa, TNF-b, IFN-g, G-CSF, GM-
CSF, MIP-1a, MIP-1b, MCP-1, Eotaxin, IP-10) in the supernatants
was measured by using Luminex multiplex kits on a Luminex 100
multiplex bead array system (Luminex Corporation, Austin, TX,
USA) to screen for cytokines and chemokines produced by eosino-
phils cultured with sema3A, sema4A, sema4D or sema7A (1 ng/
ml) and/or IL-5 (10 ng/ml) or GM-CSF (1 ng/ml) for 48 h. These sem-
aphorins have not evident effect for production cytokines and che-
mokines induced by IL-5 or GM-CSF (data not shown). From the
above, it have been demonstrated that sema3A, sema4A, sema4D
and sema7A do not have a direct effect on eosinophils.
Recently, it was reported that sema7A expressed on eosinophils.
Sema7A protein on the surface of blood eosinophils was increased
more by IL-3 than by GM-CSF or IL-5.10 Therefore, we examined for
expression of semaphorin on eosinophils. First, we examined gene
expression of sema4D in untreated and cytokine-treated eosino-
phils by RT-PCR. Sema4D gene was expressed in untreated eosino-
phils (Fig. 1A) and not enhanced by the cytokine stimulation with
IL-1b, IL-3, IL-5, IL-33, TNF-aor TSLP (Fig. 1B). We then investigated
protein expression of the receptors by ﬂow cytometry. Sema4Dwas
expressed in untreated eosinophils and not enhanced by the cyto-
kine stimulation with IL-5 or GM-CSF (Fig. 2).
Our study showed that immune semaphorin receptors' gene
were expressed in eosinophils, but protein of these receptors
were not expressed on the surface of untreated and cytokine-
treated eosinophils from peripheral blood. Therefore, these sema-
phorins did not have direct effect on eosinophils. We used the
several cytokines (IL-3, IL-5, GM-CSF, TNF-a, b-NGF, and VEGF)
which were reported the activated effect for eosinophils or the
enhanced expression for semaphorin receptors for priming.10,11
There is a possibility that up-regulation of semaphorin receptors
and direct effect of semaphorin are led in eosinophils by other
priming methods. Previous study reported that sema7A expressed
on eosinophils and sema7A protein on the surface of blood eosino-
phils was increased more by IL-3 than by GM-CSF or IL-5.10vier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
Fig. 1. A, Detection of sema4D in untreated eosinophils by real-time RT-PCR. The average Ct for sema4D was 27.608, and for GAPDH was 27.310. Ampliﬁed PCR products were
detected by gel electrophoresis. B, Detection of sema4D in cytokine-treated eosinophils by real-time RT-PCR. RQ is expressed as fold-change using the 2DDCt method in real-
time PCR analysis.
Fig. 2. Detection of sema4D in untreated and cytokine-treated eosinophils by ﬂow cytometry. The cells were stained with isotype control antibody (isotype control), anti-sema4D
Ab and analyzed by ﬂow cytometry.
Letter to the Editor / Allergology International 64 (2015) S77eS79S78On the other hand, sema4D was expressed strongly and
constitutively on peripheral blood eosinophils. Thus, sema4D
was not upregulated any more in this study. Eosinophils are ma-
jor effector cells in asthma. Airway epithelial cells expressed
CD72 or plexin-B1. It was reported that sema4D acted as a critical
positive regulator of the severity of inﬂammation observed in
experimental allergic asthma. Its absence in vivo in Sema4D/
mice led to a downregulation of many features of allergic
response such as predominantly eosinophilic BAL and lung tissue
inﬁltration, mucous cell hyperplasia, BAL Th2 cytokine (IL-5 and
IL-13) levels. It affected T cell activation and function suggesting
its positive costimulatory role.12 Further studies are required to
deﬁne the function of eosinophil-expressed sema4D in lung
allergic inﬂammation.
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